Novartis's total assets for Q1 2026 were $118.53B, an increase of 2.56% from the previous quarter. NVS total liabilities were $79.61B for the fiscal quarter, a 15.34% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.